NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Groundwork BioAg

Groundwork BioAg

Private
IsraelHealthcare & Life Scienceshttps://groundworkbioag.com/

Last Round

Series B

Extension

Aug 18, 2022

Total Funding Raised

$36.7M

Company Overview

Groundwork BioAg is a bioagriculture company that produces highly-concentrated, cost-effective mycorrhizal inoculants to enhance crop performance and soil health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share

AI Layer

Non-AI

Keywords

mycorrhizal inoculantsbiofertilizerbiological agricultural inputssoil healthagtechcarbon creditssustainable agriculturecrop yield improvementseed treatmentregenerative agriculturenutrient uptakefungicide-compatible inoculantcarbon farming

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Groundwork BioAg Comparables

Compare Groundwork BioAg with similar companies based on industry and business-model similarity.

Groundwork BioAg comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NewLeaf Symbiotics
82%
BioConsortia, Inc.
79%
Loam Bio
79%

Groundwork BioAg Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 18, 2022
Series BAug 18, 2022
VC RoundMay 12, 2021
VC RoundMay 12, 2021
Series A ExtensionNov 1, 2016
Series B
Sep 9, 2015

Key People

Founding team and executive leadership

Dan Grotsky

Co-Founder, Chief Growth Officer, DYNOMYCO General Manager, Co-Founder, Chief Growth Officer

Founding Team

Alon Werber

Chief Executive Officer

Executive Team

Danny Levy

CTO VP Research Development

Executive Team

Bari Ruimy

Chief Financial Officer

Executive Team

Groundwork BioAg Investors

Notable investors and investment history

Groundwork BioAg investors
InvestorRounds
EdaphonSeries B, Series B Extension
bpd partnersVC Round
Ibex InvestorsSeries B, Series B Extension, VC Round
MoreVCSeries B, Seed, VC Round, Series B Extension, Series A
SRK Management CompanySeries B
ProDeltaVC Round
HSBC Asset ManagementSeries B, Series B Extension

Groundwork BioAg Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Groundwork BioAg Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Groundwork BioAg's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range54
Year Founded2014
Last FundingAug 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.